NASDAQ:NKTR

Nektar Therapeutics Stock Predictions

etoro logo Buy NKTR
*Your capital is at risk
$59.23
+0.670 (+1.14%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

NKTR Prediction Chart

NKTR Predictions History

Latest community submissions for NKTR.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 20, 2025 $56.21 -2.70% $62.99 X 89.24% 0
Oct 20, 2025 $56.80 -1.68% $62.99 X 90.17% 0
Oct 20, 2025 $73.35 +33.46% $62.99 V 83.55% 1
Oct 6, 2025 $59.16 -2.30% $59.93 V 98.71% 2
Oct 6, 2025 $59.68 -1.44% $59.93 V 99.58% 5
Oct 6, 2025 $65.52 +8.30% $59.93 X 90.67% 0
Jul 3, 2025 Bearish $24.80 V 1
May 30, 2025 $0.714 -3.37% $0.725 V 98.61% 2
May 30, 2025 $0.724 -2.11% $0.725 V 99.90% 10
May 30, 2025 Bullish $0.725 V 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NKTR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT NEKTAR THERAPEUTICS
Nektar Therapeutics
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE